Yankeelov J A, Parish H A, Spatola A F
J Med Chem. 1978 Jul;21(7):701-4. doi: 10.1021/jm00205a023.
A mercapto analogue of histidine (1), (RS)-2-mercapto-3-(5-imidazolyl)propionic acid (2), was prepared by treatment of (RS)-2-bromo-3-(5-imidazolyl)propionic acid with trithiocarbonate. Decomposition of the resulting intermediate with hydrochloric acid followed by Sephadex G-15 chromatography permitted isolation of 2 as a hydrobromide complex having unusual stability and properties as evidenced by IR and 1H NMR data. The potency of this complex in inhibiting tissue (Rana catesbiana) collagenase was estimated by radial diffusion assay. The amount of 2 required to produce 50% inhibition was 3.8 +/- 1.5 mM compared to 8.7 +/- 2.5 mM for cysteine. Preliminary tests of oxygen susceptibility, mutagenicity, and toxicity suggest that this substance may warrant study as a therapeutic agent for control of collagenase-linked corneal ulcerations.
通过用三硫代碳酸盐处理(RS)-2-溴-3-(5-咪唑基)丙酸制备了组氨酸的巯基类似物(1),即(RS)-2-巯基-3-(5-咪唑基)丙酸(2)。用盐酸分解所得中间体,然后进行葡聚糖凝胶G-15柱色谱,得到2的氢溴酸盐络合物,其具有不寻常的稳定性和性质,红外光谱和1H核磁共振数据证明了这一点。通过径向扩散测定法评估了该络合物抑制组织(牛蛙)胶原酶的效力。产生50%抑制所需的2的量为3.8±1.5 mM,而半胱氨酸为8.7±2.5 mM。对氧敏感性、致突变性和毒性的初步测试表明,该物质作为控制胶原酶相关角膜溃疡的治疗剂可能值得研究。